Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28036052 | 0.98 | MAPT (0.36) | MAPTMAPK1ALDH1A1 | |
| SCHEMBL1754856 | 0.97 | — | — | |
| SCHEMBL15825944 | 0.76 | KDM4E (0.39) | ALDH1A1 | |
| SCHEMBL2923420 | 0.74 | — | — | |
| SCHEMBL8850067 | 0.73 | GPR119 (0.31) | — | |
| SCHEMBL12374748 | 0.71 | — | — | |
| SCHEMBL12374739 | 0.71 | — | — | |
| SCHEMBL22093047 | 0.70 | — | — | |
| SCHEMBL10337202 | 0.70 | LPAR3 (0.39) | MAPTALDH1A1 | |
| SCHEMBL9289027 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129107-A1 | HYDROSILYLATION PROCESS PHOTOCATALYSED BY A MANGANESE COMPLEX | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2025-04-24 | — | — | US | claimed |
| CN-119343356-A | Hydrosilylation process by manganese complex photocatalysis | 埃肯有机硅法国简易股份公司 | 2025-01-21 | — | — | CN | claimed |
| EP-2935287-B1 | METHOD FOR THE HYDROSILYLATION OF A SILOXANE PHOTOCATALYSED BY A POLYOXOMETALATE COMPOUND | BLUESTAR SILICONES FRANCE (FR) | 2016-12-14 | — | — | EP | claimed |
| US-9475829-B2 | Method for the hydrosilylation of a siloxane photocatalysed by a polyoxometalate compound | BLUESTAR SILICONES FRANCE SAS (FR) | 2016-10-25 | — | — | US | claimed |
| US-20150315214-A1 | METHOD FOR THE HYDROSILYLATION OF A SILOXANE PHOTOCATALYSED BY A POLYOXOMETALATE COMPOUND | BLUESTAR SILICONES FRANCE SAS (FR) | 2015-11-05 | — | — | US | claimed |
| US-8921380-B2 | Pyrazolo[1,5-a] pyrimidine compounds as CB1 receptor antagonist | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2014-12-30 | — | — | US | claimed |
| US-20120202992-A1 | PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST | TANIMOTO KOICHI (JP) | 2012-08-09 | — | — | US | claimed |
| US-20090258867-A1 | PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-10-15 | — | — | US | claimed |
| EP-2035427-A2 | PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST | Mitsubishi Tanabe Pharma Corporation (JP) | 2009-03-18 | — | — | EP | claimed |
| WO-2008004698-A2 | PYRAZOLO [1, 5-A] PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-01-10 | — | — | WO | claimed |
| US-20040224967-A1 | Phenylaminopyrimidine derivatives and methods of use | CHEN GUOQING P | 2004-11-11 | — | — | US | claimed |
| US-20250129107-A1 | HYDROSILYLATION PROCESS PHOTOCATALYSED BY A MANGANESE COMPLEX | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2025-04-24 | — | — | US | disclosed |
| CN-119343356-A | Hydrosilylation process by manganese complex photocatalysis | 埃肯有机硅法国简易股份公司 | 2025-01-21 | — | — | CN | disclosed |
| US-20240287255-A1 | HYDROSILYLATION METHOD CATALYSED BY AN IRON COMPLEX | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-08-29 | — | — | US | disclosed |
| EP-3354688-B1 | POLYACETAL RESIN COMPOSITION AND MOLDED BODY THEREOF | ASAHI CHEMICAL IND (JP) | 2024-03-13 | — | — | EP | disclosed |
| EP-0244027-A2 | Process for the synthesis of allylated derivatives of 2,2,6,6-tetraalkylpiperidinols | ENICHEM SYNTHESIS S.p.A. (IT) | 1987-11-04 | — | — | EP | disclosed |
| US-4329352-A | ANTIARRHYTHMIA AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1982-05-11 | — | — | US | disclosed |
| US-4329352-A | ANTIARRHYTHMIA AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1982-05-11 | — | — | US | disclosed |
| US-4315939-A | Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, pharmaceutical formulations containing these compounds and use in treating cardiac arrhythmias | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | disclosed |
| US-4315939-A | Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, pharmaceutical formulations containing these compounds and use in treating cardiac arrhythmias | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202992-A1 | PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST | CNR1, CNR2, CCKAR | MAPT 4458/4885MAPK1 508/4885ALDH1A1 2507/4885 |
| US-20090258867-A1 | PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST | CNR1, CNR2, CCKAR | MAPT 4396/4885MAPK1 524/4885ALDH1A1 2256/4885 |
| US-20250129107-A1 | HYDROSILYLATION PROCESS PHOTOCATALYSED BY A MANGANESE COMPLEX | C9, PIEZO1, HMOX1 | MAPT 4246/4885MAPK1 2928/4885ALDH1A1 548/4885 |
| US-20150315214-A1 | METHOD FOR THE HYDROSILYLATION OF A SILOXANE PHOTOCATALYSED BY A POLYOXOMETALATE COMPOUND | HAO2, HAAO, PPOX | MAPT 3848/4885MAPK1 4531/4885ALDH1A1 686/4885 |
| US-20040224967-A1 | Phenylaminopyrimidine derivatives and methods of use | ABL1, ABL2, LCK | MAPT 1427/4885MAPK1 405/4885ALDH1A1 331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.